Third-party benchmark claims GPT-6 Astra leads frontier models at antibody developability prediction
gdb · x · 2026-09-11
Account @andrewaiginin reports that its benchmark shows "GPT-6 Astra" outperforming other frontier models at predicting antibody developability — whether an antibody will aggregate, stay stable, and behave like a real drug. An interactive antibody visualization was reportedly also built with Astra in about 1 hour. Note: neither the model name nor this third-party eval is officially confirmed.
More from Models
- Persimmon unveiled: first large-scale model to simulate human conversation — niloofar_mire · 2026-09-11
- DeepSeek V4 training details: RL beyond collapse, WSD schedule, 1M context over 10T tokens — stochasticchasm · 2026-09-11
- Neel Nanda replicates Astra system card: no-CoT reasoning jumps 1.75x over next-best models — NeelNanda5 · 2026-09-11
- OpenAI pauses Pro subscriptions due to overwhelming demand — Charuru · 2026-09-11
- Artificial Analysis isn't broken: self-funded benchmarks, $13k spent on one model — Antblue · 2026-09-11
- Claude checkpoint diagnostician jokes Opus 3 is 'the cure' after newer model quirks — repligate · 2026-09-11